Argo Therapeutics

Switzerland
Allschwil, Basel-Landschaft, Switzerland, CH-4123

Company profile

Argo Therapeutics company profile

Argo Therapeutics is a developer of inventive therapeutics to deliver a cure for neurological disorders. The company offers a pipeline of drug candidates that target a multi-acting nuclear receptor Nurr1 which is required for the development of dopaminergic neurons.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2020-01-01, Year

Headquarters

Postal code
CH-4123
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Founders
2
Articles
1

Founders and investors

Founders

Alexander BreidenbachAthanasios Spathis